Know Cancer

or
forgot password

Prospective Clinical Study to Determine the Predictive Value of Sniffer Dogs to Identify Lung Cancer in the Exhalation of Patients With and Without Pulmonary Disease


Phase 1
18 Years
80 Years
Not Enrolling
Both
Lung Cancer, Chronic Obstructive Airway Disease

Thank you

Trial Information

Prospective Clinical Study to Determine the Predictive Value of Sniffer Dogs to Identify Lung Cancer in the Exhalation of Patients With and Without Pulmonary Disease


All breath samples (BS) are collected in patients on the basis of radiologic findings before
any intervention (bronchoscopy, biopsy or surgery) has been performed. The allocation to
study groups is made following diagnostic work up and surgery.

Three study groups are defined using the following inclusion and exclusion criteria:

- lung cancer: male & female, age 18-80, competent, confirmed lung cancer in diagnostic
work up and surgery, no history or present other tumor disease

- healthy individual: male & female, age 18-80, competent, no history or present other
tumor disease including lung cancer, no pathological lung function tests

- chronic obstructive lung disease: male & female, age 18-80, competent, no history or
present other tumor disease including lung cancer, pathological lung function tests

For each patient, i) history, ii) present medication, iii) lung function tests are
documented. For the lung cancer patients, the tumor stage following surgery is documented.

Five sniffer dogs are trained using BS of lung cancer patients and healthy individuals.
After completion of the training the ability of the dogs to differentiate between the groups
is tested:

- 5 BS are presented in 1 experiment:

- Test I: lung cancer vs healthy individual

- Test II: lung cancer vs chronic obstructive pulmonary disease

- Test III: lung cancer vs healthy individuals & bronchitis

- for every experiment 1 BS of a lung cancer patient is used

- the lung cancer sample is placed randomly in one of the five test tubes

- the other test tubes are used for BS of healthy individuals or chronic obstructive
pulmonary disease patients or both

- neither the dog handler nor the dog know the loading of the test tubes

- experiments are repeated 5 to 10 times

For analysis, the sensitivity and specificity of the dog's reaction is determined.

The patient's medication, smoking habits, age and gender are analysed to rule out
confounders or bias.


Inclusion Criteria:



- age 18-80

- competent

- confirmed lung cancer

Exclusion Criteria:

- history of other cancers

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Diagnostic

Outcome Measure:

presence of an heretofore unknown substrate in the exhalation sample of a patient with confirmed lung cancer

Outcome Description:

number of individuals in the study cohort with confirmed lung cancer whose exhalation sample is correctly identified by sniffer dogs to contain an heretofore unknown substrate that is associated with lung cancer

Outcome Time Frame:

baseline

Safety Issue:

No

Principal Investigator

Thorsten Walles, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Schillerhoehe Hospital

Authority:

Germany: Ethics Commission

Study ID:

KSH-TCH-IIT-2010-1

NCT ID:

NCT01141842

Start Date:

November 2009

Completion Date:

May 2010

Related Keywords:

  • Lung Cancer
  • Chronic Obstructive Airway Disease
  • lung cancer
  • exhalation analysis
  • chronic obstructive pulmonary disease
  • cancer screening test
  • Lung Diseases
  • Pulmonary Disease, Chronic Obstructive
  • Lung Neoplasms
  • Lung Diseases, Obstructive

Name

Location